Picture of Sichuan Kelun-Biotech Biopharmaceutical logo

6990 — Sichuan Kelun-Biotech Biopharmaceutical News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Brief: Sichuan Kelun-Biotech Biopharmaceutical Receives NMPA Approval For IND Application For SKB118 (CR-001)

May 13 (Reuters) - Sichuan Kelun-Biotech Biopharmaceutical Co Ltd 6990.HK:

RECEIVES NMPA APPROVAL FOR IND APPLICATION FOR SKB118 (CR-001) FOR ADVANCED SOLID TUMORS

Further company coverage: 6990.HK

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Sichuan Kelun-Biotech Biopharmaceutical

See all news